CompletedNot Applicable

Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3)

United States32 participantsStarted 2020-02-08

Plain-language summary

The purpose of this multi-reader, multi-case (MRMC) reader study is to evaluate reader performance when SoftVue™ automated breast ultrasound and screening mammography are combined, compared to screening mammography alone, in women with dense breast parenchyma. This reader study will include up to 32 radiologist readers and a sample of 140 breast screening cases that were selected from the library of images collected under Delphinus Protocol #DMT-2015.001 (NCT03257839) Arm 1 Phase B. The reader study image case set will be enriched with cancer cases.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Radiologists of any age, sex, race, ethnicity, or institutional affiliation may participate as study readers. All readers must meet the following base Inclusion Criteria: * Hold a current United States medical license * Be American Board of Radiology Certified * Be MQSA-qualified * Be experienced in reading DM images on a monitor * Be experienced in reading Breast Ultrasound images on a monitor * Have completed a Financial Disclosure showing no Conflicts of Interest * Have provided a current curriculum vitae (CV) * Have provided a signed Readers' Agreement * Have provided written Informed Consent All qualified and confirmed readers will complete a multi-module SoftVue™ training program prior to their participation in a reading session for this study.

What they're measuring

MRMC Analysis: ROC AUC

Timeframe: 8 Weeks

Trial details

NCT IDNCT04260620

SponsorDelphinus Medical Technologies, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2020-03-03

View on ClinicalTrials.gov More Breast Cancer Detection trials